论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
胰腺类肝细胞癌手术切除联合动脉化疗栓塞和免疫治疗:一病例报告
Authors He J, Zhao Q, Liu Q, Li F, He L, Liu M, Yan X
Received 8 June 2021
Accepted for publication 24 July 2021
Published 26 August 2021 Volume 2021:14 Pages 4575—4578
DOI https://doi.org/10.2147/OTT.S323811
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Arseniy Yuzhalin
Abstract: Pancreatic hepatoid carcinoma (HC) is a heterogeneous tumor with high degree of malignancy and poor prognosis, which display cytological and/or structural features of focal hepatocellular carcinoma (HCC). For the low incidence and atypical clinical symptoms, it is possible to be diagnosed as pancreatic cancer before operation, and mainly depending on the pathological examination. To the best of our knowledge, surgery combined with radiotherapy and chemotherapy is the common treatment of pancreatic HC. However, the curative effect and prognosis is poor. We report a case of 44-year-old woman with pancreatic HC treated with PD-1 receptor inhibitor and transarterial chemoembolization, whose clinical symptoms and laboratory indexes are significantly improved after treatment.
Keywords: pancreatic hepatoid carcinoma, surgical resection, transarterial chemoembolization, immunotherapy, case report